Measles and Rubella Strategic Framework 2021-2030 - Midterm review

At the midpoint of the Measles & Rubella Strategic Framework (MRSF) 2021–2030, this Midterm Review assesses global progress toward measles and rubella elimination and identifies the course corrections needed to achieve 2030 targets. While notable progress has been made, the world remains off-track to reach elimination targets. Persistent immunity gaps, rising outbreaks, inequities in access, and a tightening global health financing landscape are undermining progress. The findings below summarize the state of measles and rubella from 2021–2024 and set the stage for strategic recommendations for 2026–2030.

Auteurs